Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

PAGR1 (PA1) Rabbit anti-Human, Mouse, Polyclonal, MilliporeSigma™

Catalog No. ABE1863MI Shop All MilliporeSigma Products
Change view
Click to view available options
Quantity:
100 μg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
ABE1863MI 100 μg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. ABE1863MI Supplier MilliporeSigma Supplier No. ABE1863
Add to Cart
Add to Cart

Rabbit Polyclonal Antibody

Anti-PAGR1 (PA1) is a highly specific rabbit polyclonal antibody that targets PAXIP1-associated glutamate-rich protein 1 and has been tested in Chromatin Immunoprecipitation (ChIP), Immunocytochemistry, and Western Blotting.
TRUSTED_SUSTAINABILITY

Specifications

Antigen PAGR1 (PA1)
Applications ChIP Assay, Western Blot
Classification Polyclonal
Concentration Please refer to lot specific datasheet.
Conjugate Unconjugated
Gene Symbols PAGR1,C16orf53,PA1
Host Species Rabbit
Immunogen His-tagged full-length human recombinant PAXIP1-associated protein 1.
Purification Method Affinity Purified
Quantity 100 μg
Regulatory Status RUO
Research Discipline Epigenetics and Nuclear Function
Primary or Secondary Primary
Gene ID (Entrez) NP_078792
Test Specificity This polyclonal antibody detects PAXIP1-associated glutamate-rich protein 1 in human and mouse.
Target Species Human, Mouse
Content And Storage Stable for 1 year at 2-8°C from date of receipt.
Form Purified
Isotype IgG
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.